Literature DB >> 20360007

Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition.

Oleg Timofeev1, Onur Cizmecioglu, Florian Settele, Tore Kempf, Ingrid Hoffmann.   

Abstract

Progression through mitosis requires the coordinated regulation of Cdk1 kinase activity. Activation of Cdk1 is a multistep process comprising binding of Cdk1 to cyclin B, relocation of cyclin-kinase complexes to the nucleus, activating phosphorylation of Cdk1 on Thr(161) by the Cdk-activating kinase (CAK; Cdk7 in metazoans), and removal of inhibitory Thr(14) and Tyr(15) phosphorylations. This dephosphorylation is catalyzed by the dual specific Cdc25 phosphatases, which occur in three isoforms in mammalian cells, Cdc25A, -B, and -C. We find that expression of Cdc25A leads to an accelerated G(2)/M phase transition. In Cdc25A-overexpressing cells, Cdk1 exhibits high kinase activity despite being phosphorylated on Tyr(15). In addition, Tyr(15)-phosphorylated Cdk1 binds more cyclin B in Cdc25A-overexpressing cells compared with control cells. Consistent with this observation, we demonstrate that in human transformed cells, Cdc25A and Cdc25B, but not Cdc25C phosphatases have an effect on timing and efficiency of cyclin-kinase complex formation. Overexpression of Cdc25A or Cdc25B promotes earlier assembly and activation of Cdk1-cyclin B complexes, whereas repression of these phosphatases by short hairpin RNA has a reverse effect, leading to a substantial decrease in amounts of cyclin B-bound Cdk1 in G(2) and mitosis. Importantly, we find that Cdc25A overexpression leads to an activation of Cdk7 and increase in Thr(161) phosphorylation of Cdk1. In conclusion, our data suggest that complex assembly and dephosphorylation of Cdk1 at G(2)/M is tightly coupled and regulated by Cdc25 phosphatases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20360007      PMCID: PMC2878026          DOI: 10.1074/jbc.M109.096552

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

1.  Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells.

Authors:  Stéphane Larochelle; Karl A Merrick; Marie-Emilie Terret; Lara Wohlbold; Nora M Barboza; Chao Zhang; Kevan M Shokat; Prasad V Jallepalli; Robert P Fisher
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

2.  Human Cdc25A phosphatase has a non-redundant function in G2 phase by activating Cyclin A-dependent kinases.

Authors:  Oleg Timofeev; Onur Cizmecioglu; Entan Hu; Thomas Orlik; Ingrid Hoffmann
Journal:  FEBS Lett       Date:  2009-02-02       Impact factor: 4.124

3.  Rapid destruction of human Cdc25A in response to DNA damage.

Authors:  N Mailand; J Falck; C Lukas; R G Syljuâsen; M Welcker; J Bartek; J Lukas
Journal:  Science       Date:  2000-05-26       Impact factor: 47.728

4.  Specificity of natural and artificial substrates for human Cdc25A.

Authors:  J Rudolph; D M Epstein; L Parker; J Eckstein
Journal:  Anal Biochem       Date:  2001-02-01       Impact factor: 3.365

5.  The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.

Authors:  J Falck; N Mailand; R G Syljuåsen; J Bartek; J Lukas
Journal:  Nature       Date:  2001-04-12       Impact factor: 49.962

6.  Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis.

Authors:  M Molinari; C Mercurio; J Dominguez; F Goubin; G F Draetta
Journal:  EMBO Rep       Date:  2000-07       Impact factor: 8.807

7.  Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.

Authors:  S Garrett; W A Barton; R Knights; P Jin; D O Morgan; R P Fisher
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

8.  S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells.

Authors:  B Hu; J Mitra; S van den Heuvel; G H Enders
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

9.  p107wee1 is a dual-specificity kinase that phosphorylates p34cdc2 on tyrosine 15.

Authors:  L L Parker; S Atherton-Fessler; H Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

10.  Cyclin B1-Cdk1 activation continues after centrosome separation to control mitotic progression.

Authors:  Arne Lindqvist; Wouter van Zon; Christina Karlsson Rosenthal; Rob M F Wolthuis
Journal:  PLoS Biol       Date:  2007-05       Impact factor: 8.029

View more
  51 in total

1.  Effect of sesquiterpene lactone coronopilin on leukaemia cell population growth, cell type-specific induction of apoptosis and mitotic catastrophe.

Authors:  R Cotugno; R Fortunato; A Santoro; D Gallotta; A Braca; N De Tommasi; M A Belisario
Journal:  Cell Prolif       Date:  2011-12-14       Impact factor: 6.831

2.  Chk2-mediated G2/M cell cycle arrest maintains radiation resistance in malignant meningioma cells.

Authors:  Venkateswara Rao Gogineni; Arun Kumar Nalla; Reshu Gupta; Dzung H Dinh; Jeffrey D Klopfenstein; Jasti S Rao
Journal:  Cancer Lett       Date:  2011-09-06       Impact factor: 8.679

3.  Hyperphosphorylation by cyclin B/CDK1 in mitosis resets CUX1 DNA binding clock at each cell cycle.

Authors:  Laurent Sansregret; David Gallo; Marianne Santaguida; Lam Leduy; Ryoko Harada; Alain Nepveu
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

4.  IFI27, a novel epidermal growth factor-stabilized protein, is functionally involved in proliferation and cell cycling of human epidermal keratinocytes.

Authors:  W-L Hsieh; Y-H Huang; T-M Wang; Y-C Ming; C-N Tsai; J-H S Pang
Journal:  Cell Prolif       Date:  2015-02-09       Impact factor: 6.831

5.  CASZ1 inhibits cell cycle progression in neuroblastoma by restoring pRb activity.

Authors:  Zhihui Liu; Julieann Rader; Stanley He; Tanya Phung; Carol J Thiele
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

6.  Part II-mechanism of adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints.

Authors:  Madeeha Aqil; Zane Deliu; Kim M Elseth; Grace Shen; Jiaping Xue; James A Radosevich
Journal:  Tumour Biol       Date:  2013-11-17

7.  CyclinD-CDK4/6 complexes phosphorylate CDC25A and regulate its stability.

Authors:  C Dozier; L Mazzolini; C Cénac; C Froment; O Burlet-Schiltz; A Besson; S Manenti
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

8.  Overexpression of thioredoxin-binding protein 2 increases oxidation sensitivity and apoptosis in human lens epithelial cells.

Authors:  Yibo Yu; Kuiyi Xing; Rilwan Badamas; Charles A Kuszynski; Hongli Wu; Marjorie F Lou
Journal:  Free Radic Biol Med       Date:  2013-01-04       Impact factor: 7.376

Review 9.  The role of Cdc25A in the regulation of cell proliferation and apoptosis.

Authors:  Tao Shen; Shile Huang
Journal:  Anticancer Agents Med Chem       Date:  2012-07       Impact factor: 2.505

10.  Reduction of nitric oxide level leads to spontaneous resumption of meiosis in diplotene-arrested rat oocytes cultured in vitro.

Authors:  Ashutosh N Pandey; Shail K Chaube
Journal:  Exp Biol Med (Maywood)       Date:  2014-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.